Kohjin Bio KBM 550BA (Culture medium for activated human T cell expansion in a gas-permeable bag)

Kohjin Bio KBM 550BA (Culture medium for activated human T cell expansion in a gas-permeable bag)

Kohjin Bio KBM 550BA (Culture medium for activated human T cell expansion in a gas-permeable bag)

KBM 550BA is used for the expansion culture of activated T cells and the addition of serum may be omitted during expansion culture.

Add to cart
Description

Product Description

KBM 550BA description

  • This product is KBM 550 packed in a cell culture bag.
    The cell culture bag has excellent gas permeability.
  • This product can be used for the expansion culture of activated T cells cultured in KBM 550.
  • The addition of serum (plasma) may be omitted during the expansion culture.
  • This product contains human interleukin-2 (IL-2) in 109 JRU/mL (175 IU/mL).

Product Features
・The bag filling reduces the risk of contamination.
​・This product contains no protein other than human serum albumin, recombinant human insulin and recombinant human interleukin-2.
​・Buffering capacity is enhanced to minimize pH fluctuation.
​・It contains kanamycin sulfate as an antibiotic.
​・The KBM 550BA and KBM 550BEL use Maccell bags made of different materials, but the components of the medium are the same as those of the KBM 550.

  • Shelf life of each medium is comparatively longer even in the presence of L-glutamine.
  • The products are manufactured at Kohjin Bio’s certified ISO 9001 and ISO 13485 factories.
CODE 1602550C 1602550A
VOLUME 350ml 1,000ml
CAPACITY Liquid
PRESERVATION 2-8℃
EXPIRATION DATE 240days
Reference Publications

Reference Publications

Kawamoto, M., Onishi, H., Koya, N. et al.

Stage IV gastric cancer successfully treated by multidisciplinary therapy including chemotherapy, immunotherapy, and surgery: a case report.

surg case rep 3, 112 (2017).

DOI: https://doi.org/10.1186/s40792-017-0380-5

Article Snippet: “Secondly, non-adherent cells among the patient’s PBMCs were cultured with autologous tumor-pulsed DCs for 1 week in low dose IL-2, then expanded in OKT3-coated flasks followed by culture in oxygen-permeable bags (KBM550BA-M; Kojin-Bio, Saitama, Japan).”

 

 

Documents